解读2007年ESH/ESC高血压指南被引量：32

Interpretation of the ESH/ESC hypertension guidelines published in 2007

导出

摘要 2007年,欧洲高血压学会和欧洲心脏学会(ESH/ESC)联合公布了高血压诊治新指南,从全面评估、治疗方法与策略以及特殊人群的处理等方面的集中反映了高血压最新进展,更新了评估指标,强调了及早降压,更严格更快降压和强化联合治疗的重要性,要求防治重心前移。新的指南对目前高血压的诊治具有重要的指导意义。 European Society of Hypertension/European Society of Cardiology jointly published new guidelines on diagnosis and treatment of hypertension in 2007. It reflected the the latest developments on comprehensive assessment, treatment modalities and strategies, as well as therapeutic approach for special populations. In addition, the new guidelines updated evaluation. It also stressed the importance of an early,faster and more stringent treatment and aggressive combination therapy. More impartantly,it requested prevention and treatment earlier. It is of great importance for the guidelines to guide the current diagnosis and treatment of hypertension.

作者马长生乔岩

机构地区首都医科大学附属北京安贞医院

出处《中国实用内科杂志》 CAS CSCD 北大核心 2009年第9期798-800,I0001,共4页 Chinese Journal of Practical Internal Medicine

关键词高血压指南 hypertension guidelines

分类号 R5 [医药卫生—内科学]

引文网络
相关文献

参考文献7

1Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension:The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) [J]. Eur Heart J,2007,28 : 1462 - 1536.
2Weber MA, Julius S, Kjeldsen SE,et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE trial[ J]. Lancet,2004,363:2049- 2051.
3Pepine C J, Kowey PR, Kupfer S, et al. Predictors of adverse outcome among patients with hypertension and coronary artery disease [J]. J Am Coll Cardiol,2006,47:547 -551.
4Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine:the VALUE randomised trial[ J ]. Lancet, 2004,363:2022 - 2031.
5Dahlof B, Sever PS, Pouher NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) : a multicentre randomised controlled trial [J].Lancet,2005,366 : 895 - 906.
6Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone:the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group [ J ]. Jama, 2000,283 : 1967 - 1975.
7Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction : the CHARM-Preserved trial [ J ]. Lancet, 2003, 362:777 -781.